Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - IDERA PHARMACEUTICALS, INC. | idra_ex312.htm |
| EX-10.57 - EX-10.57 - IDERA PHARMACEUTICALS, INC. | idra_ex1057.htm |
| 10-K/A - 10-K/A - IDERA PHARMACEUTICALS, INC. | idra_currentfolio10ka.htm |
Exhibit 31.1
Certification of Chief Executive Officer pursuant to Exchange
Act Rules 13a-14 and 15d-14, as adopted pursuant to
Section 302 of Sarbanes-Oxley Act of 2002
I, Vincent J. Milano, certify that:
|
1. |
I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Idera Pharmaceuticals, Inc.; and |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|
|
|
|
|
|
|
|
|
|
|
/s/ Vincent J. Milano |
|
|
Vincent J. Milano |
|
|
Chief Executive Officer |
Dated: March 16, 2017